RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Ombow, >>> unrealized potential <<<

That's why it's a microcap. Once the potential is realized, it will be a mid cap.

One thing I'm confident about is that there won't be a liquidation, where no one is interested in the assets of the company. I have confidence that when the final partnering/buyout bids are placed, we'll see at least several multiples of the current .22 cent range.

Yes, you might get a lower entry point in early Oct if the SA trial bombs, or later if the delisting appeal is rejected prior to a pharma deal. That's why I'm keeping 50% in reserve. On the other hand, if SA shows some efficacy (early Oct), then up we go.

As for the delisting appeal timeline, I'd be interested in finding out exactly when the appeal hearing was requested. The hearing is scheduled for within 45 days of the request. Once the hearing happens, I'm not sure how long it is after that for Cortex to get the final decision. But if Cortex has a pharma deal before that, then the cash infusion from the deal would presumably justify another appeal process/re-evalution.

Anyway, I'm not going to worry about the delisting issue that much since I think the timeline will probably extend past our timeline for a pharma deal. For the SA results, we should get those in early Oct, and I have some dry powder ready in case the results aren't good.

But the key event for the pps is going to be the late Oct/early Nov announcement of the pharma deal or MA/buyout. That will be the main driver for the pps.